Home/Filings/3/0001079974-15-000255
3//SEC Filing

OMNI BIO PHARMACEUTICAL, INC. 3

Accession 0001079974-15-000255

CIK 0001389870operating

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 6:07 PM ET

Size

8.2 KB

Accession

0001079974-15-000255

Insider Transaction Report

Form 3
Period: 2014-09-25
Holdings
  • Warrant

    Exercise: $0.25From: 2014-04-18Exp: 2019-12-31Common Stock (1,000,000 underlying)
  • Convertible Note

    Exercise: $0.20From: 2014-06-16Exp: 2015-04-24Common Stock (2,500,000 underlying)
  • Convertible Note

    Exercise: $0.20From: 2014-09-25Exp: 2015-04-24Common Stock (2,500,000 underlying)
  • Convertible Note

    Exercise: $0.20From: 2014-04-25Exp: 2015-04-24Common Stock (2,500,000 underlying)
Footnotes (3)
  • [F1]This Secured Convertible Promissory Note gives the holder the right but not the obligation to convert the principal and accrued interest into common stock at a purchase price per share equal to the lesser of $0.20 or in the event of a follow-on public offering, 65% of the price offered. The note is for up-to $2,0000,000 at 12% interest of which $500,000 was advanced.
  • [F2]Advance of $500,000 under the previously disclosed $2,000,000 Secured Convertible Promissory Note resulting in total drawn principal of $1,000,000.
  • [F3]Advance of $500,000 under the previously disclosed $2,000,000 Secured Convertible Promissory Note resulting in total drawn principal of $1,500,000.

Issuer

OMNI BIO PHARMACEUTICAL, INC.

CIK 0001389870

Entity typeoperating
IncorporatedCO

Related Parties

1
  • filerCIK 0001389870

Filing Metadata

Form type
3
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 6:07 PM ET
Size
8.2 KB